Cerenome (CNSY) EBT Margin (QoQ) (2011 - 2026)
Powered by 
Analysis
Cerenome (CNSY) EBT Margin (QoQ) (2011 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 141.52 Bn | 133.66 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 86.69 Bn | 78.69 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.63 Bn | 59.45 Bn | 1.37 Bn |
| 4 | Moderna | 59.30 Bn | 54.16 Bn | 52.00 Mn |
| 5 | Revolution Medicines | 44.41 Bn | 44.41 Bn | - |
| 6 | BeOne Medicines | 40.45 Bn | 35.35 Bn | 1.53 Bn |
| 7 | Alnylam Pharmaceuticals | 35.29 Bn | 31.98 Bn | 992.69 Mn |
| 8 | Royalty Pharma | 28.44 Bn | 27.60 Bn | - |
| 9 | Insmed | 27.55 Bn | 26.39 Bn | 358.27 Mn |
| 10 | Cerenome | 20.42 Mn | 11.83 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -151,556.00 |
| Mar 31, 2026 | -25,776.00 |
| Dec 31, 2025 | -10,132.00 |
| Sep 30, 2025 | -20,790.00 |
| Jun 30, 2025 | 27,685.00 |
| Mar 31, 2025 | -10,914.00 |
| Dec 31, 2024 | -1,680.00 |
| Sep 30, 2024 | 2,631.00 |
| Jun 30, 2024 | -9,147.00 |
| Mar 31, 2024 | 9,572.00 |
| Dec 31, 2023 | -21,702.00 |
| Sep 30, 2023 | 484.00 |
| Jun 30, 2023 | 87,160.00 |
| Mar 31, 2023 | 276,563.00 |
| Dec 31, 2022 | 347,107.00 |
| Mar 31, 2019 | -20,878.00 |
| Dec 31, 2018 | 14,648.00 |
| Sep 30, 2018 | 2,815.00 |
| Jun 30, 2018 | 30,509.00 |
| Mar 31, 2018 | -3,695.00 |